T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
951
DELISTED
Paramount Global Class B
PARA
| $38.8M | 0.01% |
668,344
-14,784
| -2% | -$934K |
|
952
Clorox
CLX
$12.9B
| $38.7M | 0.01% |
293,283
-5,072
| -2% | -$682K |
|
953
CALL
Comcast
CMCSA
$92.9B
| $38.5M | 0.01% |
+1,000,000
| New | +$39.4M |
|
954
EPAM Systems
EPAM
$5.24B
| $38.4M | 0.01% |
436,227
+175,149
| +67% | +$14.6M |
|
955
Advanced Energy
AEIS
$13.2B
| $38.2M | 0.01% |
473,076
-588,031
| -55% | -$42.6M |
|
|
SJI
956
DELISTED
South Jersey Industries, Inc.
SJI
| $38M | 0.01% |
1,101,919
+1,930
| +0.2% | +$67K |
|
|
CMD
957
DELISTED
Cantel Medical Corporation
CMD
| $37.9M | 0.01% |
402,677
+19,378
| +5% | +$1.53M |
|
958
Hartford Financial Services
HIG
$37.8B
| $37.9M | 0.01% |
683,885
-28,653
| -4% | -$1.56M |
|
959
WEC Energy
WEC
$35.9B
| $37.7M | 0.01% |
600,867
-13,336
| -2% | -$851K |
|
960
Culp Inc
CULP
$43.2M
| $37.7M | 0.01% |
1,150,777
-6,400
| -0.6% | -$193K |
|
961
Winmark
WINA
$1.26B
| $37.6M | 0.01% |
285,340
-4,100
| -1% | -$537K |
|
|
ENV
962
DELISTED
ENVESTNET, INC.
ENV
| $37.6M | 0.01% |
736,804
-108,715
| -13% | -$4.65M |
|
963
Wave Life Sciences
WVE
$1.02B
| $37.4M | 0.01% |
1,719,554
-36,477
| -2% | -$733K |
|
964
Ulta Beauty
ULTA
$22.2B
| $37.4M | 0.01% |
165,397
-4,159
| -2% | -$1M |
|
965
Ametek
AME
$58.7B
| $37.3M | 0.01% |
564,649
-13,072
| -2% | -$826K |
|
966
VF Corp
VFC
$5.79B
| $37.2M | 0.01% |
621,888
-11,915
| -2% | -$688K |
|
967
T. Rowe Price
TROW
$23.7B
| $37.1M | 0.01% |
409,757
-9,257
| -2% | -$766K |
|
968
Plains GP Holdings
PAGP
$5.04B
| $37.1M | 0.01% |
+1,696,284
| New | +$40.3M |
|
969
Galicia Financial Group
GGAL
$7.23B
| $37.1M | 0.01% |
719,387
+214,070
| +42% | +$9.16M |
|
970
Woodward
WWD
$21.2B
| $36.9M | 0.01% |
475,551
+29,457
| +7% | +$2.07M |
|
971
Chemed
CHE
$7.02B
| $36.9M | 0.01% |
182,652
+13,996
| +8% | +$2.75M |
|
972
ResMed
RMD
$32.9B
| $36.9M | 0.01% |
479,497
+102,576
| +27% | +$7.85M |
|
973
Patrick Industries
PATK
$2.78B
| $36.6M | 0.01% |
978,849
+67,014
| +7% | +$2.21M |
|
974
MKS Inc
MKSI
$20.7B
| $36.5M | 0.01% |
386,882
+20,809
| +6% | +$1.7M |
|
975
Oneok
OKE
$58.4B
| $36.5M | 0.01% |
658,759
-38,081
| -5% | -$2.06M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.